In the BioHarmony Drug Report Database
Tamoxifen
Nolvadex, Soltamox (tamoxifen) is a small molecule pharmaceutical. Tamoxifen was first approved as Nolvadex on 1982-01-01. It is used to treat breast neoplasms, gynecomastia, pancreatic neoplasms, and precocious puberty in the USA. The pharmaceutical is active against estrogen receptor. In addition, it is known to target estrogen receptor beta, G-protein coupled estrogen receptor 1, and 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase.
Trade Name
|
Nolvadex, Soltamox |
|---|---|
Common Name
|
tamoxifen |
ChEMBL ID
|
CHEMBL83 |
Indication
|
breast neoplasms, gynecomastia, pancreatic neoplasms, precocious puberty |
Drug Class
|
Selective estrogen receptor modulator |
Image (chem structure or protein)